Literature DB >> 10717793

Regional alterations in an excitatory amino-acid transporter, blood flow, and glucose metabolism after middle cerebral artery occlusion in the rat.

S Gomi1, A Karp, J H Greenberg.   

Abstract

A rise in the extracellular concentration of excitatory amino acids (EAA) plays a pivotal role in ischemic brain injury. EAA concentrations are regulated by uptake mechanisms through high-affinity EAA transporters. Since EAA uptake is energy-dependent, it is a matter of interest to explore the relationship between the EAA transporter and derangement of flow-metabolism during ischemia. We examined the regional changes in EAA transporters after permanent occlusion of the middle cerebral artery in rats by in vitro autoradiography using [3H]-D-aspartate as a ligand, and correlated these changes to the local cerebral blood flow (LCBF) and local cerebral glucose metabolism (LCMRglc) determined by in vivo double-labeled autoradiography. The values of specific binding of [3H]-D-aspartate decreased maximally by 20% in the ischemic core. The magnitude of the reduction in specific binding correlated well with the changes in LCBF and LCMRglc. In half of the regions with LCMRglc between 80 and 120% of the intact side, the values of the specific binding were relatively preserved, while in the remainder of the regions in the ischemic hemisphere, with LCMRglc ranging from 40 to 160% of the intact side, there was a reduction in specific binding. These results suggest that energy failure and the related perturbation caused by ischemia can decrease EAA uptake capacity, leading to further deterioration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10717793     DOI: 10.1007/s002219900252

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  2 in total

1.  Nimodipine does not affect the flow-metabolism couple in permanent cerebral ischemia.

Authors:  Shintaro Gomi; Mark G Burnett; Andrea Karp; Joel H Greenberg
Journal:  Exp Brain Res       Date:  2004-01-30       Impact factor: 1.972

Review 2.  Ligustrazine monomer against cerebral ischemia/reperfusion injury.

Authors:  Hai-Jun Gao; Peng-Fei Liu; Pei-Wen Li; Zhuo-Yan Huang; Feng-Bo Yu; Ting Lei; Yong Chen; Ye Cheng; Qing-Chun Mu; Hai-Yan Huang
Journal:  Neural Regen Res       Date:  2015-05       Impact factor: 5.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.